These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16024207

  • 1. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact.
    Nishimura M, Yuasa K, Mori K, Miyamoto N, Ito M, Tsurudome M, Nishio M, Kawano M, Komada H, Uchida A, Ito Y.
    J Orthop Res; 2005 Sep; 23(5):979-87. PubMed ID: 16024207
    [Abstract] [Full Text] [Related]

  • 2. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM.
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E.
    J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
    [Abstract] [Full Text] [Related]

  • 4. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA.
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N.
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [Abstract] [Full Text] [Related]

  • 6. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.
    Mori K, Miyamoto N, Higuchi Y, Nanba K, Ito M, Tsurudome M, Nishio M, Kawano M, Uchida A, Ito Y.
    Cell Immunol; 2001 Feb 01; 207(2):118-26. PubMed ID: 11243701
    [Abstract] [Full Text] [Related]

  • 7. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
    Roux S, Quinn J, Pichaud F, Orcel P, Chastre E, Jullienne A, De Vernejoul MC.
    J Cell Physiol; 1996 Sep 01; 168(3):489-98. PubMed ID: 8816903
    [Abstract] [Full Text] [Related]

  • 8. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 01; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the cytokine pattern of porcine bone marrow-derived cells treated with 1alpha,25(OH)D.
    Sipos W, Duvigneau JC, Schmoll F, Exel B, Hofbauer G, Baravalle G, Hartl RT, Dobretsberger M, Pietschmann P.
    J Vet Med A Physiol Pathol Clin Med; 2005 Oct 01; 52(8):382-7. PubMed ID: 16176565
    [Abstract] [Full Text] [Related]

  • 10. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H, Abe M, Hiura K, Wilde J, Moriyama K, Sano T, Kitazoe K, Hashimoto T, Ozaki S, Wakatsuki S, Kido S, Inoue D, Matsumoto T.
    Clin Cancer Res; 2005 Sep 01; 11(17):6109-15. PubMed ID: 16144909
    [Abstract] [Full Text] [Related]

  • 11. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.
    Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T, Yago T, Kobashigawa T, Togari A, Kamatani N.
    Eur J Immunol; 2005 Nov 01; 35(11):3353-63. PubMed ID: 16220542
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N, Colla S, Morandi F, Rizzoli V.
    Haematologica; 2004 Sep 01; 89(9):1118-23. PubMed ID: 15377473
    [Abstract] [Full Text] [Related]

  • 14. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes.
    Namba K, Nishio M, Mori K, Miyamoto N, Tsurudome M, Ito M, Kawano M, Uchida A, Ito Y.
    Cell Immunol; 2001 Nov 01; 213(2):104-13. PubMed ID: 11831872
    [Abstract] [Full Text] [Related]

  • 15. Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells.
    Miyamoto N, Higuchi Y, Mori K, Ito M, Tsurudome M, Nishio M, Yamada H, Sudo A, Kato K, Uchida A, Ito Y.
    Int Immunopharmacol; 2002 Jan 01; 2(1):25-38. PubMed ID: 11789667
    [Abstract] [Full Text] [Related]

  • 16. Regulation of RANKL-induced osteoclastic differentiation by vascular cells.
    Tintut Y, Abedin M, Cho J, Choe A, Lim J, Demer LL.
    J Mol Cell Cardiol; 2005 Aug 01; 39(2):389-93. PubMed ID: 15893766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IL-4, but not vitamin D(3), induces monoblastic cell line UG3 to differentiate into multinucleated giant cells on osteoclast lineage.
    Kaji Y, Ikeda K, Ikeda T, Kawakami K, Sasaki K, Shindo M, Hatake K, Harada M, Motoyoshi K, Mori S, Norimatsu H, Takahara J.
    J Cell Physiol; 2000 Feb 01; 182(2):214-21. PubMed ID: 10623885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
    Ma T, Miyanishi K, Suen A, Epstein NJ, Tomita T, Smith RL, Goodman SB.
    Cytokine; 2004 May 07; 26(3):138-44. PubMed ID: 15135808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.